Generic pricing antitrust lawsuit claims have become one of the largest antitrust actions in American legal history. This massive litigation alleges that generic drug manufacturers conspired to fix prices on hundreds of medications. The scheme reportedly affected millions of consumers, pharmacies, hospitals, and insurance companies nationwide. Prices on some generic drugs increased by more than ten times their normal cost. The federal MDL consolidates claims from across the country into a single proceeding in Pennsylvania.
Case Timeline
Last checked: June 04, 2026
What Is the Generic Pricing Antitrust Lawsuit About?
The generic pricing antitrust lawsuit targets pharmaceutical companies that allegedly conspired to inflate prices on generic drugs. Generic medications are supposed to be affordable alternatives to brand-name drugs. However, investigators discovered that competing manufacturers were secretly agreeing to raise prices together. They also allegedly rigged bids and divided up customers among themselves.
The conspiracy reportedly involved dozens of generic drug manufacturers. Affected medications include antibiotics, diabetes treatments, cholesterol drugs, cancer medications, and topical ointments. For example, doxycycline and glyburide were among the first drugs identified in the scheme. The scope eventually expanded to cover hundreds of generic pharmaceuticals sold throughout the United States.
The U.S. Department of Justice launched a criminal investigation into the price-fixing conduct. Heritage Pharmaceuticals admitted to participating in price-fixing schemes in 2019. Multiple executives faced federal criminal charges for their roles in the conspiracy. As a result, both civil and criminal proceedings continue to unfold against remaining defendants.
MDL Case Status and Key Facts
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-2875 |
| Pending Cases | 1,424 |
| Presiding Judge | TBD |
| Federal District | TBD |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | June 01, 2026 |
| Detail | Information |
|---|---|
| MDL Number | MDL-2875 |
| Presiding Judge | Judge Cynthia M. Rufe |
| Federal District | Eastern District of Pennsylvania |
| Approximate Case Count | 1,420+ |
| Key Defendants | Teva, Sandoz, Mylan, Heritage, Lannett, Bausch Health |
| State AG Trial | Expected late 2026 in Hartford, Connecticut |
The MDL consolidates claims from direct purchasers, indirect resellers, and end payors. Direct purchasers include wholesalers and distributors. Indirect resellers include pharmacies and hospitals. End payors include consumers and insurance companies. Each plaintiff class has separate settlement tracks and timelines.
In most cases, settlement hearings continue on a rolling basis as individual defendants resolve claims. A settlement fairness hearing with Breckenridge Pharmaceutical is scheduled for November 2026. Meanwhile, a coalition of 48 state attorneys general continues parallel litigation against 30 remaining corporate defendants and 25 individual executives. The first state trial is anticipated in late 2026.
Who Qualifies for the Generic Pricing Antitrust Lawsuit?
Eligibility for the generic pricing antitrust lawsuit depends on your role in the pharmaceutical supply chain. You may qualify if you purchased affected generic drugs during the relevant time period. Typically, the conspiracy period spans from approximately 2012 through the present. However, specific dates vary by drug and defendant.
Direct purchasers such as wholesalers and pharmacies that bought directly from manufacturers have the strongest claims. Indirect purchasers including consumers who paid out-of-pocket costs may also be eligible. Insurance companies and third-party payors that covered affected medications might qualify as well. For example, if you filled prescriptions for affected generics and paid inflated prices, you might be eligible for recovery.
Evidence that strengthens a claim includes pharmacy records, insurance statements, and prescription histories. You do not need to prove you knew prices were inflated at the time of purchase. The class action structure means individual consumers typically do not need to file separate lawsuits. However, consulting a licensed attorney can help determine whether your specific situation qualifies.
How to File a Generic Pricing Antitrust Lawsuit Claim
Filing a claim in the generic pricing antitrust lawsuit typically involves joining an existing class action. Most consumers are automatically included as class members if they purchased affected drugs. However, you should verify your eligibility through the official settlement website. The court-approved administrator maintains records of qualifying purchases and settlement distributions.
For businesses and institutional purchasers, the process involves more documentation. Pharmacies, hospitals, and insurers typically need to submit proof of purchase for affected generic medications. A licensed attorney experienced in antitrust litigation can guide institutional plaintiffs through plaintiff fact sheet requirements. In most cases, there are no upfront costs because attorneys work on contingency.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Statutes of limitations vary by state and claim type. Federal antitrust claims under the Sherman Act carry a four-year limitations period. State law claims may have different deadlines. As a result, potential claimants should not delay in seeking legal counsel. The sooner you consult an attorney, the better your chances of preserving your rights.
Settlement Updates and What to Expect
The generic pricing antitrust lawsuit has already produced substantial settlements. Total recoveries across all plaintiff classes have exceeded one billion dollars. Major manufacturers including Teva, Sandoz, Heritage, and others have reached agreements. Settlement amounts vary significantly depending on the defendant and scope of the conspiracy.
In February 2026, a 48-state coalition announced settlements with Lannett Company and Bausch Health. These agreements resolved allegations of widespread price manipulation. Both companies agreed to implement antitrust compliance programs. Additional settlements with remaining defendants are expected as litigation continues toward trial.
Individual recovery amounts vary based on several factors. These include the volume of affected drugs purchased, the price inflation percentage, and the plaintiff class category. Typically, direct purchasers recover more per dollar spent than end payors. The timeline for receiving settlement payments depends on final court approval and claims administration processing. Most distributions occur six to twelve months after final approval.
State-by-State Considerations
State laws significantly affect how the generic pricing antitrust lawsuit impacts claimants in different jurisdictions. Connecticut leads the multistate attorney general litigation and will host the first trial. Pennsylvania, New York, Massachusetts, and California have particularly large plaintiff populations. Each state’s antitrust laws may provide additional recovery options beyond federal claims.
Some states have indirect purchaser statutes that allow consumers to sue for antitrust damages. Others follow the federal rule limiting claims to direct purchasers. Typically, states with strong consumer protection laws offer additional avenues for recovery. You should consult an attorney familiar with your state’s specific antitrust framework. State tort reform laws including damage caps and procedural requirements vary widely and can affect potential recoveries.
Frequently Asked Questions
How long will the generic pricing antitrust lawsuit take to resolve?
The litigation has been active since 2016 and continues with ongoing settlements and upcoming trials. Full resolution against all defendants may take several more years. However, individual settlements are being approved and distributed on a rolling basis.
Do I need to do anything to receive a settlement payment?
It depends on your plaintiff class. Some consumer class members receive automatic distributions based on pharmacy records. Others may need to file a proof of claim form through the official settlement administrator. Consulting a licensed attorney ensures you do not miss any filing deadlines.
Can I file a generic pricing antitrust lawsuit claim if I had insurance?
Yes, you might be eligible even if insurance covered your prescriptions. Consumers who paid copays or coinsurance on affected drugs may qualify as end payors. Your insurance company may also have its own separate claim in the litigation. Both insured and uninsured purchasers are potentially eligible for recovery.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Georgia Tort Reform Guide
- New Jersey Tort Reform Guide
- North Carolina Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.